PUNCH CD3-OLS: a phase 3 prospective observational cohort study to evaluate the safety and efficacy of fecal microbiota, live-jslm (REBYOTA) in adults with recurrent Clostridioides difficile infection.
Paul FeuerstadtTeena ChopraWhitfield KnappleNicholas W Van HiseErik R DubberkeBrian BaggottBeth GuthmuellerLindy BanckeMichael GamborgTheodore S SteinerDaniel Van HandelSahil KhannaPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
The study is registered at ClinicalTrials.gov (NCT03931941).
Keyphrases